BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8073180)

  • 1. Effects of intravenous infusions of cholecystokinin-8 and pentagastrin on plasma concentrations of insulin and glucagon in sheep.
    Mineo H; Iwaki N; Onaga T; Kato S
    Res Vet Sci; 1994 May; 56(3):298-302. PubMed ID: 8073180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous infusions of cholecystokinin (CCK)-8 on exocrine and endocrine pancreatic secretion in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Zabielski R; Onaga T; Kato S
    Comp Biochem Physiol A Physiol; 1995 May; 111(1):133-8. PubMed ID: 7537612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
    Mineo H; Kamita H; Muto H; Ito M; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):171-4. PubMed ID: 9243718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep.
    Mineo H; Ito M; Muto H; Kamita H; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):105-10. PubMed ID: 9243706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK-octapeptide injected into cerebral ventricles of sheep decreases plasma insulin level.
    Della-Fera MA; Baile CA
    Physiol Behav; 1985 Feb; 34(2):283-9. PubMed ID: 3889948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exogenous cholecystokinin and secretin on pancreatic secretion of insulin and glucagon in rats: in vivo model without hepatic filter.
    Ferrer RL; Medrano J; Calpena R; Diego M; Graells ML; Molto MV; Pérez MT; Oliver MI; Salido GM
    Dig Dis Sci; 2001 Oct; 46(10):2127-33. PubMed ID: 11680586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic insulin secretion after intravenous but not after intraportal CCK-8 infusion in rats.
    Balkan B; Steffens AB; Strubbe JH; Bruggink JE
    Diabetes; 1990 Jun; 39(6):702-6. PubMed ID: 2189762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the voluntary intake of food by sheep. 3. The effect of intravenous infusions of gastrin, cholecystokinin and secretin on motility of the reticulo-rumen and intake.
    Grovum WL
    Br J Nutr; 1981 Jan; 45(1):183-201. PubMed ID: 7470434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intravenous cholecystokinin, secretin and pentagastrin on electromyographic activity of the rumen in sheep.
    Kermani RZ; Rezaiee A
    Regul Pept; 1993 Jun; 45(3):371-7. PubMed ID: 8351402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composition of amino acid infusions and effect of cholecystokinin on insulin release in dogs.
    Schmid R; Schusdziarra V; Butscher H; Classen M
    Clin Physiol Biochem; 1990; 8(5):244-9. PubMed ID: 2103898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1984 May; 114(5):1770-5. PubMed ID: 6143659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CCK on insulin, glucagon, and pancreatic polypeptide levels in humans.
    Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
    Pancreas; 1989; 4(6):653-61. PubMed ID: 2682604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B; Gingerich RL; Havel PJ
    Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholecystokinin-related peptides on periodic pancreatic secretion in fasting dogs.
    Magee DF; Naruse S
    J Physiol; 1988 Sep; 403():15-25. PubMed ID: 2908120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
    Banarer S; McGregor VP; Cryer PE
    Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopamine on human gastric and pancreatic secretion.
    Valenzuela JE; Defilippi C; Diaz G; Navia E; Merino Y
    Gastroenterology; 1979 Feb; 76(2):323-6. PubMed ID: 759261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.